<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37623441</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4426</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>26</Day></PubDate></JournalIssue><Title>Journal of personalized medicine</Title><ISOAbbreviation>J Pers Med</ISOAbbreviation></Journal><ArticleTitle>Longitudinal Analysis of Pulmonary Function Impairment One Year Post-COVID-19: A Single-Center Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1190</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jpm13081190</ELocationID><Abstract><AbstractText>Persistent pulmonary impairment post-COVID-19 has been reported, albeit variably. This single-center observational study aims to longitudinally evaluate pulmonary function in 140 COVID-19 survivors one year after recovery, assessing associations with disease severity and pre-existing lung conditions. Participants aged 18 and older, with confirmed SARS-CoV-2 infection, were evaluated using spirometry and Diffusion Capacity of Lungs for Carbon Monoxide (DLCO) tests. Pulmonary function parameters like Forced Expiratory Volume at 1 s (FEV1), Forced Vital Capacity (FVC), and Total Lung Capacity (TLC) were measured. Participants were stratified by age, gender, body mass index, smoking status, and lung damage severity via computed tomography (CT). The cohort consisted of mostly males (58.6%), with a mean age of 53.8 years and body mass index of 24.9 kg/m<sup>2</sup>. Post-COVID fibrosis was seen in 22.7%, 27.3%, and 51.9% of mild, moderate, and severe disease patients, respectively (<i>p</i> = 0.003). FVC significantly reduced with disease severity (<i>p</i> &lt; 0.001), while FEV1, FEF25-75, and DLCO showed a non-significant downward trend. FEV1/FVC ratio increased with disease severity (<i>p</i> = 0.033), and TLC and RV significantly declined (<i>p</i> = 0.023 and <i>p</i> = 0.003, respectively). A one-year follow-up indicated a non-significant change in FVC, FEV1, FEV1/FVC ratio, FEF25-75, and RV compared with the 40-day measurement, but it revealed significant improvements in DLCO and TLC (<i>p</i> = 0.010). There were significant mean increases in FVC, FEV1, DLCO, TLC, and RV across all disease severities over one year. They were most pronounced in the patients with a history of severe COVID-19, who had a better recovery over one year, compared with the mild and moderate COVID-19 patients whose lung function almost normalized. One year after the SARS-CoV-2 infection, we observed a significant association between disease severity and post-COVID fibrotic changes. Though some lung function parameters remained stable over the year, significant improvements were noted in DLCO and TLC. Particularly, individuals with severe disease showed substantial recovery in lung function, indicating the potential reversibility of COVID-19-related pulmonary damage.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Suppini</LastName><ForeName>Noemi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Discipline of Pulmonology, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Research and Innovation in Precision Medicine of Respiratory Diseases (CRIPMRD), "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Doctoral School, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fira-Mladinescu</LastName><ForeName>Ovidiu</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-9034-5218</Identifier><AffiliationInfo><Affiliation>Discipline of Pulmonology, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Research and Innovation in Precision Medicine of Respiratory Diseases (CRIPMRD), "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Traila</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Discipline of Pulmonology, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Research and Innovation in Precision Medicine of Respiratory Diseases (CRIPMRD), "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Motofelea</LastName><ForeName>Alexandru Catalin</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0003-4297-077X</Identifier><AffiliationInfo><Affiliation>Center for Research and Innovation in Precision Medicine of Respiratory Diseases (CRIPMRD), "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marc</LastName><ForeName>Monica Steluta</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0003-1160-9164</Identifier><AffiliationInfo><Affiliation>Discipline of Pulmonology, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Research and Innovation in Precision Medicine of Respiratory Diseases (CRIPMRD), "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manolescu</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Center for Research and Innovation in Precision Medicine of Respiratory Diseases (CRIPMRD), "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology and Medical Imaging, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vastag</LastName><ForeName>Emanuela</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Discipline of Pulmonology, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Research and Innovation in Precision Medicine of Respiratory Diseases (CRIPMRD), "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maganti</LastName><ForeName>Ram Kiran</ForeName><Initials>RK</Initials><Identifier Source="ORCID">0009-0007-1709-1243</Identifier><AffiliationInfo><Affiliation>School of General Medicine, Sri Devaraj Urs Academy of Higher Education and Research, Karnataka 563103, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oancea</LastName><ForeName>Cristian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-2083-0581</Identifier><AffiliationInfo><Affiliation>Discipline of Pulmonology, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Research and Innovation in Precision Medicine of Respiratory Diseases (CRIPMRD), "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Pers Med</MedlineTA><NlmUniqueID>101602269</NlmUniqueID><ISSNLinking>2075-4426</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">lung diseases</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">pulmonary function tests</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>25</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>25</Day><Hour>12</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>25</Day><Hour>9</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37623441</ArticleId><ArticleId IdType="pmc">PMC10455572</ArticleId><ArticleId IdType="doi">10.3390/jpm13081190</ArticleId><ArticleId IdType="pii">jpm13081190</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X., Liu L., Shan H., Lei C.L., Hui D.S.C., et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020;382:1708&#x2013;1720. doi: 10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  WHO Coronavirus (COVID-19) Dashboard.  [(accessed on 7 May 2023)].  Available online:  https://covid19.who.int/</Citation></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo X., Jian W., Su Z., Chen M., Peng H., Peng P., Lei C., Chen R., Zhong N., Li S. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur. Respir. J. 2020;55:2001217. doi: 10.1183/13993003.01217-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01217-2020</ArticleId><ArticleId IdType="pmc">PMC7236826</ArticleId><ArticleId IdType="pubmed">32381497</ArticleId></ArticleIdList></Reference><Reference><Citation>Frija-Masson J., Debray M.P., Gilbert M., Lescure F.X., Travert F., Borie R., Khalil A., Crestani B., d&#x2019;Ortho M.P., Bancal C. Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection. Eur. Respir. J. 2020;56:2001754. doi: 10.1183/13993003.01754-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01754-2020</ArticleId><ArticleId IdType="pmc">PMC7301832</ArticleId><ArticleId IdType="pubmed">32554533</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrino R., Viegi G., Brusasco V., Crapo R.O., Burgos F., Casaburi R., Coates A., van der Grinten C.P., Gustafsson P., Hankinson J., et al. Interpretative strategies for lung function tests. Eur. Respir. J. 2005;26:948&#x2013;968. doi: 10.1183/09031936.05.00035205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.05.00035205</ArticleId><ArticleId IdType="pubmed">16264058</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi H., Han X., Jiang N., Cao Y., Alwalid O., Gu J., Fan Y., Zheng C. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: A descriptive study. Lancet Infect. Dis. 2020;20:425&#x2013;434. doi: 10.1016/S1473-3099(20)30086-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30086-4</ArticleId><ArticleId IdType="pmc">PMC7159053</ArticleId><ArticleId IdType="pubmed">32105637</ArticleId></ArticleIdList></Reference><Reference><Citation>British Thoracic Society  . British Thoracic Society Guidance on Respiratory Follow up of Patients with a Clinico-Radiological Diagnosis of COVID-19 Pneumonia. British Thoracic Society; London, UK: 2021.  [(accessed on 7 May 2023)]. pp. 1&#x2013;15. Available online:  https://www.brit-thoracic.org.uk/document-library/quality-improvement/covid-19/resp-follow-up-guidance-post-covid-pneumonia.</Citation></Reference><Reference><Citation>You J., Zhang L., Ni-Jia-Ti M.Y., Zhang J., Hu F., Chen L., Dong Y., Yang K., Zhang B., Zhang S. Anormal pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients after discharge. J. Infect. 2020;81:e150&#x2013;e152. doi: 10.1016/j.jinf.2020.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.06.003</ArticleId><ArticleId IdType="pmc">PMC7273134</ArticleId><ArticleId IdType="pubmed">32512021</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong K.C., Ng A.W., Lee L.S., Kaw G., Kwek S.K., Leow M.K., Earnest A. 1-year pulmonary function and health status in survivors of severe acute respiratory syndrome. Chest. 2005;128:1393&#x2013;1400. doi: 10.1378/chest.128.3.1393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.128.3.1393</ArticleId><ArticleId IdType="pmc">PMC7094739</ArticleId><ArticleId IdType="pubmed">16162734</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui D.S., Joynt G.M., Wong K.T., Gomersall C.D., Li T.S., Antonio G., Ko F.W., Chan M.C., Chan D.P., Tong M.W., et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax. 2005;60:401&#x2013;409. doi: 10.1136/thx.2004.030205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2004.030205</ArticleId><ArticleId IdType="pmc">PMC1758905</ArticleId><ArticleId IdType="pubmed">15860716</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P., Li J., Liu H., Han N., Ju J., Kou Y., Chen L., Jiang M., Pan F., Zheng Y., et al. Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: A 15-year follow-up from a prospective cohort study. Bone Res. 2020;8:8. doi: 10.1038/s41413-020-0084-5. Erratum in Bone Res. 2020, 8, 34.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41413-020-0084-5</ArticleId><ArticleId IdType="pmc">PMC7018717</ArticleId><ArticleId IdType="pubmed">32128276</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuttall F.Q. Body Mass Index: Obesity, BMI, and Health: A Critical Review. Nutr. Today. 2015;50:117&#x2013;128. doi: 10.1097/NT.0000000000000092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NT.0000000000000092</ArticleId><ArticleId IdType="pmc">PMC4890841</ArticleId><ArticleId IdType="pubmed">27340299</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham B.L., Steenbruggen I., Miller M.R., Barjaktarevic I.Z., Cooper B.G., Hall G.L., Hallstrand T.S., Kaminsky D.A., McCarthy K., McCormack M.C., et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am. J. Respir. Crit. Care Med. 2019;200:e70&#x2013;e88. doi: 10.1164/rccm.201908-1590ST.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201908-1590ST</ArticleId><ArticleId IdType="pmc">PMC6794117</ArticleId><ArticleId IdType="pubmed">31613151</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  . Living Guidance for Clinical Management of COVID-19. World Health Organization; Geneva, Switzerland: 2021.  [(accessed on 7 May 2023)]. p. 63. Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1.</Citation></Reference><Reference><Citation>Wei J., Yang H., Lei P., Fan B., Qiu Y., Zeng B., Yu P., Lv J., Jian Y., Wan C. Analysis of thin-section CT in patients with coronavirus disease (COVID-19) after hospital discharge. J. X-ray Sci. Technol. 2020;28:383&#x2013;389. doi: 10.3233/XST-200685.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/XST-200685</ArticleId><ArticleId IdType="pmc">PMC7369060</ArticleId><ArticleId IdType="pubmed">32474479</ArticleId></ArticleIdList></Reference><Reference><Citation>Guler S.A., Ebner L., Aubry-Beigelman C., Bridevaux P.O., Brutsche M., Clarenbach C., Garzoni C., Geiser T.K., Lenoir A., Mancinetti M., et al. Pulmonary function and radiological features 4 months after COVID-19: First results from the national prospective observational Swiss COVID-19 lung study. Eur. Respir. J. 2021;57:2003690. doi: 10.1183/13993003.03690-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03690-2020</ArticleId><ArticleId IdType="pmc">PMC8082329</ArticleId><ArticleId IdType="pubmed">33419891</ArticleId></ArticleIdList></Reference><Reference><Citation>Krueger T., van den Heuvel J., van Kampen-van den Boogaart V., van Zeeland R., Mehagnoul-Schipper D.J., Barten D.G., Knarren L., Maas A.F.G., Wyers C.E., Gach D., et al. Pulmonary function three to five months after hospital discharge for COVID-19: A single centre cohort study. Sci. Rep. 2023;13:681. doi: 10.1038/s41598-023-27879-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-27879-8</ArticleId><ArticleId IdType="pmc">PMC9839688</ArticleId><ArticleId IdType="pubmed">36639404</ArticleId></ArticleIdList></Reference><Reference><Citation>Bretas D.C., Leite A.S., Mancuzo E.V., Prata T.A., Andrade B.H., Oliveira J.D.G.F., Batista A.P., Machado-Coelho G.L.L., Augusto V.M., Marinho C.C. Lung function six months after severe COVID-19: Does time, in fact, heal all wounds? Braz. J. Infect. Dis. 2022;26:102352. doi: 10.1016/j.bjid.2022.102352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjid.2022.102352</ArticleId><ArticleId IdType="pmc">PMC9042802</ArticleId><ArticleId IdType="pubmed">35500646</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou J.N., Sun L., Wang B.R., Zou Y., Xu S., Ding Y.J., Shen L.J., Huang W.C., Jiang X.J., Chen S.M. The characteristics and evolution of pulmonary fibrosis in COVID-19 patients as assessed by AI-assisted chest HRCT. PLoS ONE. 2021;16:e0248957. doi: 10.1371/journal.pone.0248957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0248957</ArticleId><ArticleId IdType="pmc">PMC7987145</ArticleId><ArticleId IdType="pubmed">33755708</ArticleId></ArticleIdList></Reference><Reference><Citation>Das K.M., Lee E.Y., Singh R., Enani M.A., Al Dossari K., Van Gorkom K., Larsson S.G., Langer R.D. Follow-up chest radiographic findings in patients with MERS-CoV after recovery. Indian. J. Radiol. Imaging. 2017;27:342&#x2013;349. doi: 10.4103/ijri.IJRI_469_16.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijri.IJRI_469_16</ArticleId><ArticleId IdType="pmc">PMC5644332</ArticleId><ArticleId IdType="pubmed">29089687</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z., Peng F., Zhou Y. Pulmonary fibrosis: A short- or long-term sequelae of severe COVID-19? Chin. Med. J. Pulm. Crit. Care Med. 2023;1:77&#x2013;83. doi: 10.1016/j.pccm.2022.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pccm.2022.12.002</ArticleId><ArticleId IdType="pmc">PMC9988550</ArticleId><ArticleId IdType="pubmed">37388822</ArticleId></ArticleIdList></Reference><Reference><Citation>Sitek A.N., Ade J.M., Chiarella S.E., Divekar R.D., Pitlick M.M., Iyer V.N., Wang Z., Joshi A.Y. Outcomes among patients with COVID-19 and asthma: A systematic review and meta-analysis. Allergy Asthma Proc. 2021;42:267&#x2013;273. doi: 10.2500/aap.2021.42.210041.</Citation><ArticleIdList><ArticleId IdType="doi">10.2500/aap.2021.42.210041</ArticleId><ArticleId IdType="pubmed">34187619</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson D.J., Busse W.W., Bacharier L.B., Kattan M., O&#x2019;Connor G.T., Wood R.A., Visness C.M., Durham S.R., Larson D., Esnault S., et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J. Allergy Clin. Immunol. 2020;146:203&#x2013;206.e3. doi: 10.1016/j.jaci.2020.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.04.009</ArticleId><ArticleId IdType="pmc">PMC7175851</ArticleId><ArticleId IdType="pubmed">32333915</ArticleId></ArticleIdList></Reference><Reference><Citation>Alqahtani J.S., Oyelade T., Aldhahir A.M., Alghamdi S.M., Almehmadi M., Alqahtani A.S., Quaderi S., Mandal S., Hurst J.R. Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis. PLoS ONE. 2020;15:e0233147. doi: 10.1371/journal.pone.0233147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0233147</ArticleId><ArticleId IdType="pmc">PMC7213702</ArticleId><ArticleId IdType="pubmed">32392262</ArticleId></ArticleIdList></Reference><Reference><Citation>Sajuthi S.P., DeFord P., Li Y., Jackson N.D., Montgomery M.T., Everman J.L., Rios C.L., Pruesse E., Nolin J.D., Plender E.G., et al. Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium. Nat. Commun. 2020;11:5139. doi: 10.1038/s41467-020-18781-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18781-2</ArticleId><ArticleId IdType="pmc">PMC7550582</ArticleId><ArticleId IdType="pubmed">33046696</ArticleId></ArticleIdList></Reference><Reference><Citation>RECOVERY Collaborative Group. Horby P., Lim W.S., Emberson J.R., Mafham M., Bell J.L., Linsell L., Staplin N., Brightling C., Ustianowski A., et al. Dexamethasone in Hospitalized Patients with COVID-19. N. Engl. J. Med. 2021;384:693&#x2013;704. doi: 10.1056/NEJMoa2021436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Beurnier A., Yordanov Y., Dechartres A., Dinh A., Debuc E., Lescure F.X., Jourdain P., Jaulmes L., Humbert M. Characteristics and outcomes of asthmatic outpatients with COVID-19 who receive home telesurveillance. ERJ Open Res. 2022;8:00012&#x2013;2022. doi: 10.1183/23120541.00012-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00012-2022</ArticleId><ArticleId IdType="pmc">PMC9501655</ArticleId><ArticleId IdType="pubmed">36284827</ArticleId></ArticleIdList></Reference><Reference><Citation>Chhiba K.D., Patel G.B., Vu T.H.T., Chen M.M., Guo A., Kudlaty E., Mai Q., Yeh C., Muhammad L.N., Harris K.E., et al. Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19. J. Allergy Clin. Immunol. 2020;146:307&#x2013;314.e4. doi: 10.1016/j.jaci.2020.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.06.010</ArticleId><ArticleId IdType="pmc">PMC7295471</ArticleId><ArticleId IdType="pubmed">32554082</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi Y.J., Park J.Y., Lee H.S., Suh J., Song J.Y., Byun M.K., Cho J.H., Kim H.J., Lee J.H., Park J.W., et al. Effect of asthma and asthma medication on the prognosis of patients with COVID-19. Eur. Respir. J. 2021;57:2002226. doi: 10.1183/13993003.02226-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02226-2020</ArticleId><ArticleId IdType="pmc">PMC7518077</ArticleId><ArticleId IdType="pubmed">32978309</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardi C., Roca E., Bigni B., Cottini M., Passalacqua G. Clinical course and outcomes of patients with asthma hospitalized for severe acute respiratory syndrome coronavirus 2 pneumonia: A single-center, retrospective study. Ann. Allergy Asthma Immunol. 2020;125:707&#x2013;709. doi: 10.1016/j.anai.2020.07.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2020.07.029</ArticleId><ArticleId IdType="pmc">PMC7395222</ArticleId><ArticleId IdType="pubmed">32745609</ArticleId></ArticleIdList></Reference><Reference><Citation>Lovinsky-Desir S., Deshpande D.R., De A., Murray L., Stingone J.A., Chan A., Patel N., Rai N., DiMango E., Milner J., et al. Asthma among hospitalized patients with COVID-19 and related outcomes. J. Allergy Clin. Immunol. 2020;5:1027&#x2013;1034.e4. doi: 10.1016/j.jaci.2020.07.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.07.026</ArticleId><ArticleId IdType="pmc">PMC7409831</ArticleId><ArticleId IdType="pubmed">32771560</ArticleId></ArticleIdList></Reference><Reference><Citation>Izquierdo J.L., Almonacid C., Gonz&#xe1;lez Y., Del Rio-Bermudez C., Ancochea J., C&#xe1;rdenas R., Lumbreras S., Soriano J.B. The impact of COVID-19 on patients with asthma. Eur. Respir. J. 2021;57:2003142. doi: 10.1183/13993003.03142-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03142-2020</ArticleId><ArticleId IdType="pmc">PMC7651839</ArticleId><ArticleId IdType="pubmed">33154029</ArticleId></ArticleIdList></Reference><Reference><Citation>Valenzuela C., Waterer G., Raghu G. Interstitial lung disease before and after COVID-19: A double threat? Eur. Respir. J. 2021;6:2101956. doi: 10.1183/13993003.01956-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01956-2021</ArticleId><ArticleId IdType="pmc">PMC8637181</ArticleId><ArticleId IdType="pubmed">34857587</ArticleId></ArticleIdList></Reference><Reference><Citation>Cilli A., Hanta I., Uzer F., Coskun F., Sevinc C., Deniz P.P., Parlak M., Altunok E., Tertemiz K.C., Ursavas A. Characteristics and outcomes of COVID-19 patients with IPF: A multi-center retrospective study. Respir. Med. Res. 2022;81:100900. doi: 10.1016/j.resmer.2022.100900.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resmer.2022.100900</ArticleId><ArticleId IdType="pmc">PMC8890788</ArticleId><ArticleId IdType="pubmed">35338917</ArticleId></ArticleIdList></Reference><Reference><Citation>Myall K.J., Martinovic J.L., West A. How COVID-19 interacts with interstitial lung disease. Breathe. 2022;18:210158. doi: 10.1183/20734735.0158-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/20734735.0158-2021</ArticleId><ArticleId IdType="pmc">PMC8908865</ArticleId><ArticleId IdType="pubmed">35284020</ArticleId></ArticleIdList></Reference><Reference><Citation>Naqvi S.F., Lakhani D.A., Sohail A.H., Maurer J., Sofka S., Sarwari A., Hadi Y.B. Patients with idiopathic pulmonary fibrosis have poor clinical outcomes with COVID-19 disease: A propensity matched multicentre research network analysis. BMJ Open Respir. Res. 2021;8:e000969. doi: 10.1136/bmjresp-2021-000969.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2021-000969</ArticleId><ArticleId IdType="pmc">PMC8354761</ArticleId><ArticleId IdType="pubmed">34376400</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H., Choi H., Yang B., Lee S.K., Park T.S., Park D.W., Moon J.Y., Kim T.H., Sohn J.W., Yoon H.J., et al. Interstitial lung disease increases susceptibility to and severity of COVID-19. Eur. Respir. J. 2021;58:2004125. doi: 10.1183/13993003.04125-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.04125-2020</ArticleId><ArticleId IdType="pmc">PMC8061231</ArticleId><ArticleId IdType="pubmed">33888524</ArticleId></ArticleIdList></Reference><Reference><Citation>Drake T.M., Docherty A.B., Harrison E.M., Quint J.K., Adamali H., Agnew S., Babu S., Barber C.M., Barratt S., Bendstrup E., et al. Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study. Am. J. Respir. Crit. Care Med. 2020;202:1656&#x2013;1665. doi: 10.1164/rccm.202007-2794OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202007-2794OC</ArticleId><ArticleId IdType="pmc">PMC7737581</ArticleId><ArticleId IdType="pubmed">33007173</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito A.J., Menon A.A., Ghosh A.J., Putman R.K., Fredenburgh L.E., El-Chemaly S.Y., Goldberg H.J., Baron R.M., Hunninghake G.M., Doyle T.J. Increased Odds of Death for Patients with Interstitial Lung Disease and COVID-19: A Case-Control Study. Am. J. Respir. Crit. Care Med. 2020;202:1710&#x2013;1713. doi: 10.1164/rccm.202006-2441LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202006-2441LE</ArticleId><ArticleId IdType="pmc">PMC7737588</ArticleId><ArticleId IdType="pubmed">32897754</ArticleId></ArticleIdList></Reference><Reference><Citation>Papiris S.A., Bouros D., Markopoulou K., Kolilekas L., Papaioannou A.I., Tzilas V., Tzouvelekis A., Fouka E., Papakosta D., Daniil Z., et al. Early COVID-19 lockdown in Greece and idiopathic pulmonary fibrosis: A beneficial &#x201c;impact&#x201d; beyond any expectation. Eur. Respir. J. 2021;57:2003111. doi: 10.1183/13993003.03111-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03111-2020</ArticleId><ArticleId IdType="pubmed">33334934</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>